Jeffrey W. Jacobs - Jun 15, 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs
Stock symbol
ARDX
Transactions as of
Jun 15, 2021
Transactions value $
-$50,609
Form type
4
Date filed
6/17/2021, 04:32 PM
Previous filing
May 21, 2021
Next filing
Aug 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Options Exercise $4.05K +7.5K +6.05% $0.54* 132K Jun 15, 2021 Direct F1
transaction ARDX Common Stock Sale -$54.7K -7.5K -5.7% $7.29 124K Jun 15, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Options Exercise $0 -7.5K -42.86% $0.00 10K Jun 15, 2021 Common Stock 7.5K $0.54 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021.
F2 This transaction was executed in multiple trades in prices ranging from $7.242 to $7.41, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The option, which was granted on August 11, 2011 and has an expiration date of August 11, 2021, is fully vested and exercisable.